Mandate

VINGE ADVISES OPUS IN CONJUNCTION WITH ACQUISITION OF DREW TECHNOLOGIES

Vinge has advised Opus Group in connection with Opus Inspection, Inc.’s acquisition of all shares in Drew Technologies Inc., Michigan USA. Drew is a leading manufacturer of vehicle analysis equipment and diagnostics equipment for the vehicle inspection industry and OEM vehicle industry. The purchase price is USD 30 million (approximately SEK 250 million) plus a possible earn-out of USD 4.4 million (approximately SEK 36.5 million).  The transaction has been financed through a cash payment of USD 25 million (approximately SEK 209 million) and a directed issue in kind to the sellers of USD 5 million (approximately SEK 42 million). The transaction is expected to be completed within a thirty day period.

Vinge’s team consisted of responsible partner Anders Strid and associates Daniel Lennartsson and Frida Bäckergren.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026